While a road-killed deer or other cervid may be a safety hazard for motorists, CWD experts view it as a potential reservoir of deadly and extremely resilient prions.
CIDRAP’s CWD contingency planning project is a collaboration of global experts preparing for a possible spillover to humans or other non-cervid species.
A recently published National Institutes of Health (NIH) study provides laboratory evidence of a strong species barrier that may prevent a chronic wasting disease (CWD) spillover from cervids such as deer to humans. While this is good news, the study authors noted that the finding doesn't preclude the possibility of a spillover, which remains a significant concern and a focus of our work.
The CIDRAP CWD Resource Center hosts webinars featuring natural and international experts.
We provide a monthly roundup of the top news, research, and events related to CWD.
Stay in touch with CIDRAP CWD via Twitter (X) for the latest news and research.
Conversations with experts representing hunter groups, prion biology, diagnostics and epidemiology, wildlife management and health, and human health.
Receive CWD updates in your inbox
High-flow oxygen didn't significantly lower death rates beyond those of standard oxygen therapy in COVID-19 patients with respiratory failure, according to a multicenter randomized clinical trial published yesterday in JAMA.
In the first known estimate of the SARS-CoV spillover risk from bats to people, researchers who studied bat populations in South East Asia and interactions with humans estimate that about 66,280 people a year are infected each year. The team, based at EcoHealth Alliance, published their findings today in Nature Communications.
The sensitivity of home rapid antigen COVID-19 tests peaks 4 days after symptom onset, suggesting that a negative antigen test should be followed by a second test in 1 or 2 days, according to a prospective study published today in JAMA Internal Medicine.
Three new studies to be presented at the upcoming European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference at the end of the month demonstrate benefits of the antiviral molnupiravir against COVID-19 infections, including evidence that Merck's pill reduces symptoms of the SARS-CoV-2 virus by day 3 of administration.
For the first time, a wild white-tailed deer has been found with chronic wasting disease (CWD) in the city limits of Grand Rapids in northern Minnesota, triggering the Minnesota Department of Natural Resources (DNR) to update surveillance plans across the state.
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
An analysis conducted at hospitals in Michigan found that the more antibiotic stewardship strategies a hospital reported, the lower its overuse of antibiotics at discharge, researchers reported yesterday in Clinical Infectious Diseases.
Chronic wasting disease (CWD) has been confirmed for the first time in Louisiana, the Louisiana Department of Wildlife and Fisheries (LDWF) said late last week.
Needless insurer spending on ivermectin prescriptions for COVID-19, estimated at $2.5 million in the United States for the week of Aug 13, 2021—the most recent week analyzed—would extrapolate to $130 million annually, US researchers reported yesterday in JAMA.
The Arkansas Game and Fish Commission (AGFC) recently announced the first positive chronic wasting disease (CWD) test in a hunter-harvested deer in Union County, far from the nearest known positive finding in the state.
